Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study

다국어 초록 (Multilingual Abstract)

Purpose: Although heart failure (HF) is recognized as a leading contributor to healthcare costs and a significant economic burdenworldwide, studies of HF-related costs in South Korea are limited. This study aimed to estimate HF-related costs per Korean patient per year and per visit.
Materials and Methods: This retrospective cohort study analyzed data obtained from six hospitals in South Korea. Patients with HF who experienced ≥one hospitalization or ≥two outpatient visits between January 1, 2013 and December 31, 2013 were included.
Patients were followed up for 1 year [in Korean won (KRW)].
Results: Among a total of 500 patients (mean age, 66.1 years; male sex, 54.4%), the mean 1-year HF-related cost per patient was KRW 2,607,173, which included both, outpatient care (KRW 952,863) and inpatient care (KRW 1,654,309). During the post-index period, 22.2% of patients had at least one hospitalization, and their 1-year costs per patient (KRW 8,530,290) were higher than those of patients who had only visited a hospital over a 12-month period (77.8%; KRW 917,029). Among 111 hospitalized patients, the 1-year costs were 1.7-fold greater in patients (n=52) who were admitted to the hospital via the emergency department (ED) than in those (n=59) who were not (KRW 11,040,453 vs. KRW 6,317,942; p<0.001).
Conclusion: The majority of healthcare costs for HF patients in South Korea was related to hospitalization, especially admissions via the ED. Appropriate treatment strategies including modification of risk factors to prevent or decrease hospitalization are needed to reduce the economic burden on HF patients.

참고문헌 (Reference)

1 Braunschweig F, "What are the costs of heart failure?" 13 (13): ii13-ii17, 2011

2 Stewart S, "The current cost of heart failure to the National Health Service in the UK" 4 : 361-371, 2002

3 "The Cost of Heart Failure in Ireland, Social, Economic and Health Implications of heart failure in Ireland"

4 Sun SX, "Retrospective claims database analysis to determine relationship between reninangiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction" 30 (30): 2217-2227, 2008

5 McAlister FA, "Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study" 109 : 1004-1009, 2004

6 Cleland JG, "Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis" 17 : 133-149, 2012

7 McClellan W, "Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study" 17 : 1710-1715, 2006

8 Smith DH, "Predicting costs of care in heart failure patients" 12 : 434-, 2012

9 National Institute for Health and Clinical Excellence, "New NICE guidance will improve diagnosis and treatment of chronic heart failure"

10 Health Insurance Review & Assessment Service, "National Health Insurance Statistical Yearbook"

11 Stewart S, "Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial" 60 : 1239-1248, 2012

12 Mpe MT, "Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline" 103 (103): 660-667, 2013

13 Obi EN, "Health care costs for patients with heart failure escalate nearly 3-fold in final months of life" 22 : 1446-1456, 2016

14 Krum H, "Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006" 185 : 549-557, 2006

15 Owan TE, "Epidemiology of diastolic heart failure" 47 : 320-332, 2005

16 Ahmed A, "Epidemiology of chronic kidney disease in heart failure" 4 : 387-399, 2008

17 Jung Hoon Lee, "Epidemiology of Heart Failure in Korea: Present and Future" 대한심장학회 46 (46): 658-664, 2016

18 Lee WC, "Economic burden of heart failure: a summary of recent literature" 33 : 362-371, 2004

19 Liao L, "Economic burden of heart failure in the elderly" 26 : 447-462, 2008

20 "Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America" 134 : e298-, 2016

21 Senni M, "Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991" 98 : 2282-2289, 1998

22 Kupari M, "Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study" 241 : 387-394, 1997

23 최동주, "Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure: A Report From the Korean Heart Failure Registry" 대한심장학회 41 (41): 363-371, 2011

24 Metra M, "Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy" 144 : 175-179, 2010

25 National Clinical Guideline Centre (UK)., "Acute heart failure: diagnosing and managing acute heart failure in adults"

26 Lee SE, "A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry" 16 : 700-708, 2014